<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04258280</url>
  </required_header>
  <id_info>
    <org_study_id>00001137</org_study_id>
    <nct_id>NCT04258280</nct_id>
  </id_info>
  <brief_title>Improving Genetic Counseling for BRCA+ Mothers</brief_title>
  <acronym>PCS IV</acronym>
  <official_title>Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly
      your blood relatives, are at increased risk for the disease across the lifespan. This
      includes biological children, both male and female. We do not yet know the best ways to
      educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share
      genetic information with their children or manage their thoughts and feelings. The purpose of
      this study is to help mothers make more informed choices about talking with children about
      hereditary breast cancer, provide them with age-and gender-appropriate information and
      emotional support, and improve their psychological well-being.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Communication</measure>
    <time_frame>1- and 6-months post-treatment</time_frame>
    <description>Parent-child and family communication of hereditary cancer risk.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education and counseling</intervention_name>
    <description>Education includes a workbook, counseling includes peer support.</description>
    <arm_group_label>Enhanced Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education</intervention_name>
    <description>Education includes a workbook.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Mothers self-identifying as primary caregivers to adolescents and young adults ages 13-24
        years-old, participating in genetic testing for hereditary breast cancer, adequately
        speak/read English.

        Exclusion Criteria:

        Do not meet inclusion criteria.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kenneth Tercyak, PhD</last_name>
    <phone>202-687-0802</phone>
    <email>familycom@georgetown.edu</email>
  </overall_contact>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

